Puma Biotechnology
Germany
Overview
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous), and PB357 in 2011. In 2022, Puma in-licensed global research and development and commercial rights to alisertib,
Company network
Hover or focus a node to highlight its relationships. Select a line to see what connects two objects.
Related companies share an industry or country with this company.
View relationships as a table
| From | To | What connects them |
|---|---|---|
| Puma Biotechnology | Germany | IC360 lists Puma Biotechnology in Germany. |
| 1. DC Deggendorf | Germany | IC360 lists 1. DC Deggendorf in Germany. |
| 1. FC 1906 Lichtenfels | Germany | IC360 lists 1. FC 1906 Lichtenfels in Germany. |
| 1. FC 1919 Mainstockheim | Germany | IC360 lists 1. FC 1919 Mainstockheim in Germany. |
| 1. FC 1921 Langfurth | Germany | IC360 lists 1. FC 1921 Langfurth in Germany. |
| 1. FC 1921 Winterhausen | Germany | IC360 lists 1. FC 1921 Winterhausen in Germany. |
